ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry

BACKGROUND: Treatment resistant depression (TRD) affects 10–30% of patients with major depressive disorder. In 4-week trials, esketamine nasal spray (NS) was efficacious vs. placebo when both were initiated in addition to a new selective serotonin or serotonin norepinephrine reuptake inhibitor. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Oliveira-Maia, Albino J., Morrens, Joachim, Rive, Benoit, Godinov, Yordan, Cabrieto, Jedelyn, Perualila, Nolen, Barbreau, Sebastien, Mulhern-Haughey, Siobhán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669153/
https://www.ncbi.nlm.nih.gov/pubmed/38025433
http://dx.doi.org/10.3389/fpsyt.2023.1250980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669153/
https://www.ncbi.nlm.nih.gov/pubmed/38025433
http://dx.doi.org/10.3389/fpsyt.2023.1250980

Ejemplares similares